Eleven Excelera Member Pharmacists Earn Exclusive “Certified Specialty Pharmacist” Accreditation

“This certification marks a significant achievement for these pharmacy professionals,” said Don Amorosi, Chief Operating Officer at Excelera.

MINNEAPOLIS (PRWEB) December 10, 2019
Excelera®, the company behind the Excelera Network, a nationwide network of leading health systems and academic medical centers with specialty pharmacies, today announced that eleven member pharmacists have earned or recertified the exclusive Certified Specialty Pharmacist (CSP) credential from the Specialty Pharmacy Certification Board (SPCB). The newly CSP-certified and recertified pharmacists in the Excelera Network are:
Kris Jensen, PharmD, CSP – Billings ClinicChris Larson, PharmD, CSP – Billings ClinicRichard McAuliffe, PharmD, CSP – CHI HealthKami Nolan, PharmD, CSP – CHI HealthBrandon Cressall, PharmD, CSP – Intermountain HealthcareClint Ivie, PharmD, CSP, MBA – Intermountain HealthcareKatie Moore, PharmD, CSP – Intermountain HealthcareBernice Man, PharmD, BCPS, CSP – Northwestern MedicineMulham Alassad, RPh, CSP – Partners HealthcareWilliam Barrows, RPh, CSP – Partners HealthcareLisa See, PharmD, CSP – Partners Healthcare
The SPCB’s certification process is a voluntary program, differing from the obligatory and state-specific licensure process. It provides certification at a national level, allowing pharmacy professionals to verify their aptitude in specialty pharmacy along with their designated specialized areas. The CSP credential is a key indicator to employers, manufacturers, patients, payers and other healthcare providers that a professional is highly trained and competent in a variety of practice settings. The Excelera Network accounts for seven percent of the 930 currently designated as active CSP certificants.
“This certification marks a significant achievement for these pharmacy professionals,” said Don Amorosi, Chief Operating Officer at Excelera. “Their commitment to excellence drives the success of our collaborative network and reaffirms our belief that the Excelera Network has some of the most qualified specialty pharmacists in the industry.”
For a full list of the Excelera member pharmacists who have achieved the CSP accreditation, visit:
About The Excelera® NetworkThe Excelera® Network is comprised of integrated delivery networks, health systems, and large academic medical centers with a deep commitment to caring for complex patients. Through national-scale collaboration, the network more efficiently gains access to limited distribution drugs, utilizes tools, technology, and best practices to deliver high quality care.
ExceleraRx Corp is a healthcare company that empowers integrated delivery networks, health systems, and large academic medical centers to provide integrated care for complex patients, leading to improved health outcomes and decreased healthcare costs. To learn more, visit or follow us on LinkedIn.

Share article on social media or email:

Pharmacists Announce HERO Score Results, Challenging the Healthcare Industry to Deliver Measurable Improvements in Patient Outcomes and Superior Value

OptiMed’s breakthrough algorithm radically changes the way employers evaluate the quality and value of their specialty pharmaceutical spending.
Press Release – updated: Nov 5, 2019 11:00 EST

KALAMAZOO, Mich., November 5, 2019 ( – ​OptiMed Specialty Pharmacy announced the release of a case study demonstrating the Health Economics Return & Outcomes (HERO) Score for an inflammatory bowel disease (IBD) patient on a high-cost specialty medication.  Their breakthrough algorithm changes the way employers critically evaluate the quality and value of their specialty pharmaceutical spending. 

“The calculation of the HERO Score provides valuable insight about a patient’s health outcomes and the value their specialty medication provides,” says Chad Henry, PharmD, CSP, a senior clinical pharmacist from OptiMed Specialty Pharmacy who led the research with fellow colleague, Lucas Dominick, PharmD. “This could change the way employers benchmark and deliver measurable improvements in patient outcomes and healthcare spending.”

Chad Henry, PharmD, CSP
Senior Clinical Executive

OptiMed assists employers in evaluating the return on healthcare dollars invested from specialty pharmaceuticals, which are a major force driving pharmacy benefit costs.
Despite being utilized by only 2% of the population, these high-cost medications account for approximately 45% of the total drug spend. 1. When including drug spending under the medical benefit, this number increases to 60% of the total drug spend. 2. The correlation between the high cost of specialty drugs and the value these medications provide to employees and employers has been difficult to estimate. The HERO Score provides an understanding of outcomes that can be viewed in aggregate to empower health plans and employers to choose their healthcare investments wisely and with confidence. 
In this highlighted case study, the HERO Score demonstrates how costs and outcome variables, such as drug price, site of infusion care, patient management, patient disease control, healthcare utilization, and quality of life, impact the value obtained from the use of a specialty medication in an inflammatory bowel disease (IBD) patient. Results indicated marked improvement in the patient outcomes and quality of life over the course of a year, once transitioned to OptiMed Specialty Pharmacy.  The value obtained from the patient’s medication therapy was far superior due to better disease control, improved quality of life, reduced healthcare utilization and enhanced productivity. This emphasizes the importance of a value assessment that incorporates all the cost variables and outcomes of any given regimen. To read the case study, click here to download the findings.
About OptiMed:  OptiMed Health Partners, headquartered in Kalamazoo, Michigan, is an independently owned and operated national health care organization. With over 25 years of experience, OptiMed leverages personalized attention to detail to deliver customized solutions that optimize patient outcomes while partnering with other health care organizations to usher in a new standard of excellence. To learn more about OptiMed’s innovative and personalized care, visit or email
About Harmonize.Healthcare:  To learn more about the Health Economics Return & Outcomes (HERO) Score, click here to download the paper or visit HARMONIZE.HEALTHCARE (H2) to learn about applying novel care strategies to positively impact your organization and truly revolutionize employee health and productivity.
Sources: (1) Express Scripts 2018 Drug Trend Report. Published Feb 2019. Available at: Accessed 8 August 2019. (2) Shah, P. Today’s Specialty Landscape. CVS Health Insights/Specialty. Available at: Accessed 8 October 2019.
Source: OptiMed Health Partners